BIOMAT Database Logo BIOMAT Database Logo

Efficacy of perampanel as an adjunctive therapy in pediatric focal epilepsy. 2023

Wei-Ran Zhang, and Liu Liu, and Lu Xu, and Yi Hua, and Xiao-Jun Su, and Pei-Fang Jiang, and Zhe-Feng Yuan, and Feng Gao
Department of Neurology, Children's Hospital, Zhejiang University School of Medicine, Hangzhou 310052, China.

UI MeSH Term Description Entries
D009570 Nitriles Organic compounds containing the -CN radical. The concept is distinguished from CYANIDES, which denotes inorganic salts of HYDROGEN CYANIDE. Nitrile
D011728 Pyridones Pyridine derivatives with one or more keto groups on the ring. Pyridinones
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D004828 Epilepsies, Partial Conditions characterized by recurrent paroxysmal neuronal discharges which arise from a focal region of the brain. Partial seizures are divided into simple and complex, depending on whether consciousness is unaltered (simple partial seizure) or disturbed (complex partial seizure). Both types may feature a wide variety of motor, sensory, and autonomic symptoms. Partial seizures may be classified by associated clinical features or anatomic location of the seizure focus. A secondary generalized seizure refers to a partial seizure that spreads to involve the brain diffusely. (From Adams et al., Principles of Neurology, 6th ed, pp317) Abdominal Epilepsy,Digestive Epilepsy,Epilepsy, Focal,Epilepsy, Simple Partial,Focal Seizure Disorder,Gelastic Epilepsy,Partial Epilepsy,Partial Seizure Disorder,Seizure Disorder, Partial,Simple Partial Seizures,Amygdalo-Hippocampal Epilepsy,Benign Focal Epilepsy, Childhood,Benign Occipital Epilepsy,Benign Occipital Epilepsy, Childhood,Childhood Benign Focal Epilepsy,Childhood Benign Occipital Epilepsy,Epilepsy, Benign Occipital,Epilepsy, Localization-Related,Epilepsy, Partial,Occipital Lobe Epilepsy,Panayiotopoulos Syndrome,Partial Seizures, Simple, Consciousness Preserved,Rhinencephalic Epilepsy,Seizure Disorder, Focal,Subclinical Seizure,Uncinate Seizures,Abdominal Epilepsies,Amygdalo-Hippocampal Epilepsies,Benign Occipital Epilepsies,Digestive Epilepsies,Disorders, Focal Seizure,Disorders, Partial Seizure,Epilepsies, Abdominal,Epilepsies, Amygdalo-Hippocampal,Epilepsies, Benign Occipital,Epilepsies, Digestive,Epilepsies, Focal,Epilepsies, Gelastic,Epilepsies, Localization-Related,Epilepsies, Occipital Lobe,Epilepsies, Rhinencephalic,Epilepsies, Simple Partial,Epilepsy, Abdominal,Focal Epilepsies,Focal Epilepsy,Focal Seizure Disorders,Gelastic Epilepsies,Lobe Epilepsy, Occipital,Localization-Related Epilepsies,Localization-Related Epilepsy,Occipital Epilepsies, Benign,Occipital Epilepsy, Benign,Occipital Lobe Epilepsies,Partial Epilepsies,Partial Epilepsies, Simple,Partial Seizure Disorders,Partial Seizures, Simple,Rhinencephalic Epilepsies,Seizure Disorders, Focal,Seizure Disorders, Partial,Seizure, Subclinical,Seizure, Uncinate,Seizures, Simple Partial,Seizures, Subclinical,Seizures, Uncinate,Simple Partial Epilepsies,Subclinical Seizures,Uncinate Seizure
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000927 Anticonvulsants Drugs used to prevent SEIZURES or reduce their severity. Anticonvulsant,Anticonvulsant Drug,Anticonvulsive Agent,Anticonvulsive Drug,Antiepileptic,Antiepileptic Agent,Antiepileptic Agents,Antiepileptic Drug,Anticonvulsant Drugs,Anticonvulsive Agents,Anticonvulsive Drugs,Antiepileptic Drugs,Antiepileptics,Agent, Anticonvulsive,Agent, Antiepileptic,Agents, Anticonvulsive,Agents, Antiepileptic,Drug, Anticonvulsant,Drug, Anticonvulsive,Drug, Antiepileptic,Drugs, Anticonvulsant,Drugs, Anticonvulsive,Drugs, Antiepileptic
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes

Related Publications

Wei-Ran Zhang, and Liu Liu, and Lu Xu, and Yi Hua, and Xiao-Jun Su, and Pei-Fang Jiang, and Zhe-Feng Yuan, and Feng Gao
Lacosamide as an adjunctive therapy in pediatric patients with refractory focal epilepsy.
June 2014, Brain & development,
Wei-Ran Zhang, and Liu Liu, and Lu Xu, and Yi Hua, and Xiao-Jun Su, and Pei-Fang Jiang, and Zhe-Feng Yuan, and Feng Gao
The efficacy of perampanel as adjunctive therapy in drug-resistant focal epilepsy in a "real world" context: focus on temporal lobe epilepsy.
August 2020, Journal of the neurological sciences,
Wei-Ran Zhang, and Liu Liu, and Lu Xu, and Yi Hua, and Xiao-Jun Su, and Pei-Fang Jiang, and Zhe-Feng Yuan, and Feng Gao
Efficacy and tolerability of oral lacosamide as adjunctive therapy in pediatric patients with pharmacoresistant focal epilepsy.
April 2011, Epilepsy & behavior : E&B,
Wei-Ran Zhang, and Liu Liu, and Lu Xu, and Yi Hua, and Xiao-Jun Su, and Pei-Fang Jiang, and Zhe-Feng Yuan, and Feng Gao
Prospective audit with adjunctive perampanel: Preliminary observations in focal epilepsy.
January 2016, Epilepsy & behavior : E&B,
Wei-Ran Zhang, and Liu Liu, and Lu Xu, and Yi Hua, and Xiao-Jun Su, and Pei-Fang Jiang, and Zhe-Feng Yuan, and Feng Gao
Efficacy and safety of levetiracetam as adjunctive therapy for refractory focal epilepsy.
April 2021, Arquivos de neuro-psiquiatria,
Wei-Ran Zhang, and Liu Liu, and Lu Xu, and Yi Hua, and Xiao-Jun Su, and Pei-Fang Jiang, and Zhe-Feng Yuan, and Feng Gao
Adverse Events During Perampanel Adjunctive Therapy in Intractable Epilepsy.
July 2018, Journal of clinical neurology (Seoul, Korea),
Wei-Ran Zhang, and Liu Liu, and Lu Xu, and Yi Hua, and Xiao-Jun Su, and Pei-Fang Jiang, and Zhe-Feng Yuan, and Feng Gao
Efficacy and safety of adjunctive treatment with perampanel in epilepsy patients.
September 2023, The Medical journal of Malaysia,
Wei-Ran Zhang, and Liu Liu, and Lu Xu, and Yi Hua, and Xiao-Jun Su, and Pei-Fang Jiang, and Zhe-Feng Yuan, and Feng Gao
Cost-effectiveness of perampanel as an adjunctive treatment for uncontrolled focal seizures in pediatric patients: a Chinese perspective.
March 2022, Annals of translational medicine,
Wei-Ran Zhang, and Liu Liu, and Lu Xu, and Yi Hua, and Xiao-Jun Su, and Pei-Fang Jiang, and Zhe-Feng Yuan, and Feng Gao
The safety and long-term efficacy of zonisamide as adjunctive therapy for focal epilepsy.
January 2015, Expert review of neurotherapeutics,
Wei-Ran Zhang, and Liu Liu, and Lu Xu, and Yi Hua, and Xiao-Jun Su, and Pei-Fang Jiang, and Zhe-Feng Yuan, and Feng Gao
Safety evaluation of perampanel as monotherapy or first adjunctive therapy in patients with epilepsy.
October 2022, Expert opinion on drug safety,
Copied contents to your clipboard!